EP1.01-61 iSEND Model as a Predictor of Efficacy in Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer: Fukushima Cohort

Journal article

Peer reviewed

N Okabe, H Mine, H Takagi, M Watanabe, S Muto, T Hasegawa, Y Shio, W Park, G Lopes and H Suzuki

Journal of thoracic oncology, Vol.14(10), pp.S935-S935

2019-10

Metrics

7 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: EP1.01-61 iSEND Model as a Predictor of Efficacy in Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer: Fukushima Cohort
Creators: N Okabe - Chest Surgery, Fukushima Medical University, Fukusima/JP
H Mine - Chest Surgery, Fukushima Medical University, Fukusima/JP
H Takagi - Chest Surgery, Fukushima Medical University, Fukusima/JP
M Watanabe - Chest Surgery, Fukushima Medical University, Fukusima/JP
S Muto - Chest Surgery, Fukushima Medical University, Fukusima/JP
T Hasegawa - Chest Surgery, Fukushima Medical University, Fukusima/JP
Y Shio - Chest Surgery, Fukushima Medical University, Fukusima/JP
W Park - University of Miami, Miami, AL/US
G Lopes - University of Miami, Miami, AL/US
H Suzuki - Chest Surgery, Fukushima Medical University, Fukusima/JP
Publication Details: Journal of thoracic oncology, Vol.14(10), pp.S935-S935
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031599681902976